S. W. Li and Q. H. Wu, “Study on Expression of CYP11B2mRNA in Kidney Tissue in Rat Models of Kidney-Yang-Deficiency Syndrome Induced by Adenine,” China Journal of Experimental Traditional Medical Formulae, Vol. 16, No. 2, 2010, pp. 64-67.
 H. R. Mortaheb, H. Kosuge, et al., “Study on Removal of Cadmium from Wastewater by Emulsion Liquid Membrane,” Journal of Hazardous Materials, Vol. 165, No. 1-3, 2009, pp. 630-636. doi:10.1016/j.jhazmat.2008.10.039
 N. Li and H. K. Lee, “Assessment of Colloid Formation and Physical State Distribution of Trace Polycyclic Aromatic Hydrocarbons in Aqueous Samples,” Analytical Chemistry, Vol. 73, No. 21, 2001, pp. 5201-5206. doi:10.1021/ac010570x
 T. S. Wiedmann and A. Ravichandran, “Ultrasonic Nebulization System for Respiratory Drug Delivery,” Pharmaceutical Development and Technology, Vol. 6, No. 1, 2001, pp. 83-89. doi:10.1081/PDT-100000016
 S. W. Li and Q. W. Wu, “Study on Expression of CYP11B2mRNA in Rat Models of Kidney-Yang-Deficiency Syndrome Tissue Induced by Adenine,” China Journal of Experimental Traditional Medical Formulae, Vol. 16, No. 2, 2010, pp. 64-67.
 Y. Li, L. Q. He, X. Zhong, J. Yi and X. B. He, “Change of Aquaporin-1 in Rat Models of Kidney-Yang-Deficiency Syndrome,” Journal of Chinese Integrative Medicine, Vol. 6, No. 5, 2008, pp. 498-501. doi:10.3736/jcim20080513
 W. X. Mei, S. X. Lao and Z. Zhong “Relationship between Gene Expressions of Aquaporin 3 and 4 and Various Degrees of Spleen-Stomach Dampness-Heat Syndrome in Chronic Superficial Gastritis,” Journal of Chinese Digestion, Vol. 8, No. 2, 2010, pp. 111-115.
 W. X. Mei and S. X. Lao, “Study on Correlation between Aquaporin 3, 4 Gene Expression in Gastric Mucosa and Severity of Pi-Wei Damp-Heat Syndrome in Patients with Chronic Superficial Gastritis,” Chinese Journal of Integrative Medicine, Vol. 27, No. 10, 2007, pp. 891-893.
 G. X. Chen, S. X. Lao and Z. X. Huang, “Effect of Chinese Herbs on Expression of Aquaporin 3,4 Gene in Gastric Mucosa of Patients with Pi-Wei Damp-Heat SyndroMe,” Chinese Journal of Integrative Medicine, Vol. 25, No. 3, 2005, pp. 199-202.
 Z. M. Zair, J. J. Eloranta and B. Stieger and G. A. Kullak-Ublick, “Pharmacokinetics of OATP (SLC21/ SLCO), OAT and OCT (SLC22) and PEPY (SLC15) Transporters in the Intestine, Liver and Kidney,” Pharmacogenomics, Vol. 9, No. 5, 2008, pp. 597-624. doi:10.2217/146224220.127.116.117
 F. S. Sarr, C. Andréand and Y. C. Guillaume, “A Novel Biochromato Graphic Oatp2 Column to Study the Transmembrane Transport of Statins,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 52, No. 1, 2010, pp. 93-98. doi:10.1016/j.jpba.2009.11.029
 B. Hagenbuch and C. Gui, “Xenobiotic Transporters of the Human Organic Anion Transporting Polypeptides (OATP) Family,” Xenobiotica, Vol. 38, No. 7-8, 2008, pp. 778-801. doi:10.1080/00498250801986951
 K. A. Wojtal, J. J. Eloranta, P. Hruz, H. Gutmann, J. Drewe, A. Staumann, C. Beglinger, M. Fried, G. A. Kullak-Ublick and S. R. Vavricka, “Changes in mRNA Expression Levels of Solute Carrier Transporters in In-flammatory Bowel Disease Patients,” Drug Metabolism and Disposition, Vol. 37, No. 9, 2009, pp. 1871-1877. doi:10.1124/dmd.109.027367
 B. Hagenbuch and P. J. Meier, “Organic Anion Transporting Polypeptides of the OATPPSLC21 Family: Phylogenetic Classificationas OATP/SLCO Superfamily, New Nomenclature and Molecular/Functional Properties,” Pflugers Arch, Vol. 447, No. 5, 2004, pp. 653-665.